CHRASTINA, Jan, Ondřej HORÁK, Michal RYZÍ, Milan BRÁZDIL, Zdeněk NOVÁK, Tomáš ZEMAN and Pavlína DANHOFER. Single-center long-term results of vagus nerve stimulation for pediatric epilepsy: a 10-17-year follow-up study. Childs nervous system. NEW YORK: SPRINGER, 2023, vol. 39, No 11, p. 3215-3224. ISSN 0256-7040. Available from: https://dx.doi.org/10.1007/s00381-023-05992-3.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Single-center long-term results of vagus nerve stimulation for pediatric epilepsy: a 10-17-year follow-up study
Authors CHRASTINA, Jan (203 Czech Republic, guarantor, belonging to the institution), Ondřej HORÁK (203 Czech Republic, belonging to the institution), Michal RYZÍ (203 Czech Republic, belonging to the institution), Milan BRÁZDIL (203 Czech Republic, belonging to the institution), Zdeněk NOVÁK (203 Czech Republic, belonging to the institution), Tomáš ZEMAN (203 Czech Republic, belonging to the institution) and Pavlína DANHOFER (203 Czech Republic, belonging to the institution).
Edition Childs nervous system, NEW YORK, SPRINGER, 2023, 0256-7040.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30210 Clinical neurology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.400 in 2022
RIV identification code RIV/00216224:14110/23:00134637
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s00381-023-05992-3
UT WoS 000992036000001
Keywords in English Seizure; Stimulation treatment; Stimulation responder; Palliative surgery
Tags 14110127, 14110131, 14110320, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Eva Dubská, učo 77638. Changed: 14/2/2024 19:56.
Abstract
PurposeA retrospective study, based on a prospectively built database, presents the results of long-term follow-up care of pediatric vagus nerve stimulation (VNS) patients in terms of seizure outcome, surgical aspects, the potential impact of maturation, and medication changes.MethodsFrom a prospectively built database, 16 VNS patients (median age 12.0 years, range 6.0 to 16.0 years; median seizure duration 6.5 years, range 2.0 to 15.5 years) followed for at least 10 years were graded as non-responder - NR (seizure frequency reduction < 50%), responder - R (reduction >= 50% and < 80%), and 80% responder - 80R (reduction >= 80%). Data about surgical aspects (battery replacement, system complications), seizure dynamics, and medication changes were taken from the database.ResultsThe early percentages of good results (80R + R) were 43.8% (year 1), 50.0% (year 2), and 43.8% (year 3). These percentages remained stable between years 10 and 12 (50% year 10; 46.7% year 11; 50% year 12) and increased in years 16 (60%) and 17 (75%). Depleted batteries were replaced in ten patients, six of whom were either R or 80R. In the four NR, the indication for replacement was improved quality of life. Three patients had VNS explanted or switched off-one had repeated asystolia and two were NR. The effect of hormonal changes in menarche on seizure was not proven. During the study, antiseizure medication was changed in all patients.ConclusionsThe study proved the efficacy and safety of VNS in pediatric patients over an exceptionally long follow-up period. The demand for battery replacements indicates a positive treatment effect.
Links
NV19-04-00343, research and development projectName: Predikce Efektu Stimulace u pacientů s Epilepsií (PRESEnCE) (Acronym: PRESEnCE)
Investor: Ministry of Health of the CR
PrintDisplayed: 31/5/2024 05:39